Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
CGTN: China's dynamic zero-COVID policy sets the foundation for reopening 2023-01-05 04:05
China's optimization of control measures lays solid foundation for COVID-19 response 2023-01-04 15:39
Everest Medicines Announces New Strategic Plans, Reinforcing Transformation into a Fully Integrated Biopharmaceutical Company 2023-01-03 16:00
CGTN: China monitors coronavirus mutations to adjust COVID-19 response 2023-01-03 08:27
CGTN: Xi Jinping salutes ordinary people's extraordinary efforts in New Year Address 2023-01-03 07:52
CGTN：How do emergency wards in China cope with increasing COVID patients? 2023-01-03 06:54
Novavax Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza Vaccine Candidates 2022-12-30 21:00
Grand Pharma Announces Successful Clinical Progress of its Oral 3CL Protease Inhibitor GS221 Against COVID-19 2022-12-30 13:23
China enters new stage in COVID-19 response 2022-12-29 22:00
CGTN: Vitality under COVID-19: China's smart ports aid increased throughput 2022-12-29 11:55
Global Times: Three years' hard effort to fight COVID-19 'worthwhile' 2022-12-28 21:38
CGTN: Vitality under COVID-19: China gears up for medical supplies 2022-12-28 00:13
Brii Biosciences Provides Update on Strategic Clinical Development Progress 2022-12-27 20:00
China to downgrade COVID-19 management to Class B 2022-12-27 18:06
Hetero's 'Nirmacom' is world's first generic version of COVID-19 oral drug 'PAXLOVID' to receive WHO Prequalification 2022-12-27 10:00
China actively optimizes COVID-19 response measures to better prepare for challenges 2022-12-26 14:32
CGTN: 'New Approaches': How China stepped up its COVID-19 treatments 2022-12-21 18:51
CGTN: New Approaches : How China pushes COVID-19 vaccine R&D and inoculation 2022-12-20 22:53
PHASE II/III CLINICAL TRIAL OF SIMCERE'S 3CL-TARGETING ANTI-SARS-COV-2 DRUG CANDIDATE COMPLETE ALL PATIENTS ENROLLMENT 2022-12-20 19:21
CGTN: New Approaches: Why China is easing its COVID-19 curbs now 2022-12-20 10:59
1 5 6 7 8 9 90